This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Membrane Protein Laboratory | |
|---|---|
| Name | Membrane Protein Laboratory |
| Established | 2008 |
| Type | Research facility |
| Location | Diamond Light Source, Harwell Campus, Oxfordshire |
| Affiliations | Diamond Light Source, Wellcome Trust, Medical Research Council |
Membrane Protein Laboratory The Membrane Protein Laboratory is a specialized research facility located at the Harwell Campus adjacent to Diamond Light Source and associated with funding bodies such as the Wellcome Trust and the Medical Research Council. The laboratory provides structural biology services to researchers from institutions like the University of Oxford, Imperial College London, and the Francis Crick Institute, supporting projects that intersect with initiatives at European Molecular Biology Laboratory, European Synchrotron Radiation Facility, and national research infrastructures.
The laboratory was established to address challenges in membrane protein structure determination at facilities including Diamond Light Source, European Synchrotron Radiation Facility, ISIS Neutron and Muon Source, and to support consortia such as the Structural Genomics Consortium, the Human Protein Atlas, and the Protein Data Bank. The team interacts with investigators from the University of Cambridge, King's College London, University College London, and industry partners like GlaxoSmithKline, AstraZeneca, and Pfizer to accelerate translational research and drug discovery efforts connected to projects led by organizations such as the Medical Research Council and the Wellcome Trust.
Research at the laboratory spans membrane protein biochemistry and structural determination methods used in collaborations with X-ray crystallography facilities at Diamond Light Source, cryo-electron microscopy centers like the Electron Bio-Imaging Centre, and spectroscopy platforms linked to the Royal Society. The group develops protocols for membrane protein expression using systems from institutions such as Addgene, CERN-linked technology transfer, and methodologies influenced by work at the European Molecular Biology Laboratory and the Max Planck Institutes. Experimental techniques include detergent screening informed by standards from the Protein Data Bank, lipidic cubic phase crystallization comparable to approaches at the Weizmann Institute of Science, and single-particle analysis methods used at the MRC Laboratory of Molecular Biology and the National Institutes of Health.
The facility is co-located with beamlines at Diamond Light Source and houses instrumentation comparable to suites at the European Synchrotron Radiation Facility, including automated crystallization robots similar to those used at the European Molecular Biology Laboratory and high-throughput screening systems used by GlaxoSmithKline and AstraZeneca. Equipment includes vitrifaction devices in the style of the Electron Bio-Imaging Centre, mass spectrometers analogous to units at the Wellcome Sanger Institute, and computational clusters interoperable with resources at the University of Oxford and the Terastructure Project. Safety and quality systems reflect standards set by agencies like the Medical Research Council and collaborate with oversight bodies such as the UK Research and Innovation.
Projects supported by the laboratory have contributed to structural models deposited in the Protein Data Bank and have advanced understanding of classes represented by targets studied at the Structural Genomics Consortium and in collaborations with the Pharmaceutical Research and Manufacturers of America. Notable research outcomes include membrane transporter structures that relate to work from groups at the MRC Laboratory of Molecular Biology and ion channel studies complementing findings from the Howard Hughes Medical Institute and the Scripps Research Institute. Collaborative efforts have informed drug-target studies conducted by Pfizer, Novartis, and academic teams at the University of Cambridge and the Francis Crick Institute.
The laboratory maintains partnerships with major research infrastructures such as Diamond Light Source, the European Synchrotron Radiation Facility, the Electron Bio-Imaging Centre, and academic centers including the University of Oxford, Imperial College London, University College London, and the Wellcome Sanger Institute. Industry collaborations involve pharmaceutical companies like GlaxoSmithKline, AstraZeneca, Pfizer, and Novartis, while consortia links include the Structural Genomics Consortium, the Human Protein Atlas, and networks coordinated by the Medical Research Council and the Wellcome Trust.
Training programs are run in conjunction with the Diamond Light Source, the Electron Bio-Imaging Centre, and universities such as the University of Oxford and the University of Cambridge, offering hands-on courses modeled after workshops at the European Molecular Biology Laboratory and summer schools similar to those hosted by the Wellcome Trust. Outreach includes collaborative symposia with the Francis Crick Institute, seminar series in partnership with Imperial College London and King's College London, and internships aligned with career programs supported by the Medical Research Council and the Royal Society.
Funding streams include grants from the Wellcome Trust, the Medical Research Council, infrastructure support from Diamond Light Source, and project contracts with industry partners such as GlaxoSmithKline and AstraZeneca. Administrative oversight involves governance practices comparable to those at the University of Oxford research offices and compliance frameworks used by the UK Research and Innovation and the Royal Society.
Category:Laboratories in the United Kingdom